12mg retatrutide Retatrutide, Experimental drug for obesity reducing 18% of adult weight Stock Photo VisualAbstract: Retatrutide reduces body weight

Oral formulations are also emerging

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review

P.LambertE.MiltonR.MarianiN.KoseM.NikkheslatN.et al

Health Canada has not approved Retatrutide for any indication as of December 2025, and the medication remains available only through research peptide suppliers for those in Canada

They work best alongside good habits like eating well and moving more

Bring them up with your healthcare provider, especially if you experience: Sustained low mood or loss of interest lasting more than two weeks Increased anxiety or panic episodes that werent present before treatment Unusual irritability or emotional reactivity that interferes with daily life Thoughts of self-harm or suicide (seek immediate help